{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:29:58Z","timestamp":1777609798826,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901425"],"award-info":[{"award-number":["81901425"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s40256-021-00492-8","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T01:02:40Z","timestamp":1627002160000},"page":"183-193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Association Between Vitamin D and Statin-Related Myopathy: A Meta-analysis"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4929-6178","authenticated-orcid":false,"given":"Qingtao","family":"Hou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caishuang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"issue":"4","key":"492_CR1","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1007\/s13311-018-0670-z","volume":"15","author":"BA Taylor","year":"2018","unstructured":"Taylor BA, Thompson PD. Statin-associated muscle disease: advances in diagnosis and management. Neurotherapeutics. 2018;15(4):1006\u201317.","journal-title":"Neurotherapeutics"},{"issue":"2","key":"492_CR2","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1161\/ATV.0000000000000073","volume":"39","author":"CB Newman","year":"2019","unstructured":"Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL 2nd, Goldstein LB, et al. Statin safety and associated adverse events: a scientific statement from the American heart association. Arterioscler Thromb Vasc Biol. 2019;39(2):e38\u201381.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"20","key":"492_CR3","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/j.jacc.2016.02.071","volume":"67","author":"PD Thompson","year":"2016","unstructured":"Thompson PD, Panza G, Zaleski A, Taylor B. Statin-associated side effects. J Am Coll Cardiol. 2016;67(20):2395\u2013410.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"492_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jacl.2012.03.003","volume":"6","author":"JD Cohen","year":"2012","unstructured":"Cohen JD, Brinton EA, Ito MK, Jacobson TA. Understanding statin use in america and gaps in patient education (USAGE): an internet-based survey of 10,138 current and former statin users. J Clin Lipidol. 2012;6(3):208\u201315.","journal-title":"J Clin Lipidol"},{"issue":"5","key":"492_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11883-007-0050-3","volume":"9","author":"KA Sewright","year":"2007","unstructured":"Sewright KA, Clarkson PM, Thompson PD. Statin myopathy: incidence, risk factors, and pathophysiology. Curr Atheroscler Rep. 2007;9(5):389\u201396.","journal-title":"Curr Atheroscler Rep"},{"issue":"3","key":"492_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/MCO.0000000000000358","volume":"20","author":"C Domingues-Faria","year":"2017","unstructured":"Domingues-Faria C, Boirie Y, Walrand S. Vitamin D and muscle trophicity. Curr Opin Clin Nutr Metab Care. 2017;20(3):169\u201374.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"492_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.atherosclerosis.2010.11.039","volume":"215","author":"A Gupta","year":"2011","unstructured":"Gupta A, Thompson PD. The relationship of vitamin D deficiency to statin myopathy. Atherosclerosis. 2011;215(1):23\u20139.","journal-title":"Atherosclerosis"},{"issue":"3","key":"492_CR8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/bcpt.12482","volume":"118","author":"ML Ovesj\u00f6","year":"2016","unstructured":"Ovesj\u00f6 ML, Skilving I, Bergman P, Rane A, Ekstr\u00f6m L, Bj\u00f6rkhem-Bergman L. Low vitamin D levels and genetic polymorphism in the vitamin D receptor are associated with increased risk of statin-induced myopathy. Basic Clin Pharmacol Toxicol. 2016;118(3):214\u20138.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"492_CR9","first-page":"56","volume":"6","author":"KD Riche","year":"2016","unstructured":"Riche KD, Arnall J, Rieser K, East HE, Riche DM. Impact of vitamin D status on statin-induced myopathy. J Clin Transl Endocrinol. 2016;6:56\u20139.","journal-title":"J Clin Transl Endocrinol"},{"key":"492_CR10","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed 1 Jun 2011"},{"issue":"1","key":"492_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/jebm.12141","volume":"8","author":"X Zeng","year":"2015","unstructured":"Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015;8(1):2\u201310.","journal-title":"J Evid Based Med"},{"issue":"11","key":"492_CR12","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"6","key":"492_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2188\/jea.15.235","volume":"15","author":"Y Hayashino","year":"2005","unstructured":"Hayashino Y, Noguchi Y, Fukui T. Systematic evaluation and comparison of statistical tests for publication bias. J Epidemiol. 2005;15(6):235\u201343.","journal-title":"J Epidemiol"},{"issue":"2","key":"492_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.7326\/M14-1659","volume":"162","author":"ES LeBlanc","year":"2015","unstructured":"LeBlanc ES, Zakher B, Daeges M, Pappas M, Chou R. Screening for vitamin D deficiency: a systematic review for the U.S. preventive services task force. Ann Intern Med. 2015;162(2):109\u201322.","journal-title":"Ann Intern Med"},{"issue":"1","key":"492_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.trsl.2008.11.002","volume":"153","author":"W Ahmed","year":"2009","unstructured":"Ahmed W, Khan N, Glueck CJ, Pandey S, Wang P, Goldenberg N, et al. Low serum 25 (OH) vitamin D levels (<\u00a032\u00a0ng\/mL) are associated with reversible myositis-myalgia in statin-treated patients. Transl Res. 2009;153(1):11\u20136.","journal-title":"Transl Res"},{"key":"492_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s13104-015-1356-9","volume":"8","author":"M Minissian","year":"2015","unstructured":"Minissian M, Agarwal M, Shufelt C, Mehta PK, Waldman T, Lentz G, et al. Do women with statin-related myalgias have low vitamin D levels? BMC Res Notes. 2015;8:449.","journal-title":"BMC Res Notes"},{"key":"492_CR17","doi-asserted-by":"publisher","unstructured":"Pennisi M, Bartolo GD, Malaguarnera G, Bella R, Lanza G, Malaguarnera M. Vitamin D serum levels in patients with statin-induced musculoskeletal pain. Dis Mark. 2019;2019:3549402. https:\/\/doi.org\/10.1155\/2019\/3549402. eCollection 2019.","DOI":"10.1155\/2019\/3549402"},{"issue":"4","key":"492_CR18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.5152\/tftrd.2015.86158","volume":"61","author":"\u00d6 Ta\u015fo\u011flu","year":"2015","unstructured":"Ta\u015fo\u011flu \u00d6, Kutsal YG, Ta\u015fo\u011flu \u0130, \u00d6zdem\u0130r O, Erdo\u011fano\u011flu Y. Is Vitamin D deficiency a risk factor for the development of statin-induced myalgia in patients receiving statins? Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi. 2015;61(4):314\u20139.","journal-title":"Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi."},{"issue":"1","key":"492_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.atherosclerosis.2011.04.037","volume":"218","author":"JM Backes","year":"2011","unstructured":"Backes JM, Barnes BJ, Ruisinger JF, Moriarty PM. A comparison of 25-hydroxyvitamin D serum levels among those with or without statin-associated myalgias. Atherosclerosis. 2011;218(1):247\u20139.","journal-title":"Atherosclerosis"},{"issue":"5","key":"492_CR20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/QAD.0000000000001397","volume":"31","author":"L Calza","year":"2017","unstructured":"Calza L, Magistrelli E, Colangeli V, Borderi M, Contadini I, Bon I, et al. Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients. AIDS. 2017;31(5):681\u20138.","journal-title":"AIDS"},{"issue":"2","key":"492_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4161\/derm.2.2.13509","volume":"2","author":"R Linde","year":"2010","unstructured":"Linde R, Peng L, Desai M, Feldman D. The role of vitamin D and SLCO1B1*5 gene polymorphism in statin-associated myalgias. Dermatoendocrinology. 2010;2(2):77\u201384.","journal-title":"Dermatoendocrinology"},{"issue":"3","key":"492_CR22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/bcpt.12482","volume":"118","author":"ML Ovesj\u00f6","year":"2015","unstructured":"Ovesj\u00f6 ML, Skilving I, Bergman P, Rane A, Ekstr\u00f6m L, Bj\u00f6rkhem-Bergman L. Low vitamin D levels and genetic polymorphism in the vitamin D receptor are associated with increased risk of statin-induced myopathy. Basic Clin Pharmacol Toxicol. 2015;118(3):214\u20138.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"492_CR23","doi-asserted-by":"publisher","first-page":"e88877","DOI":"10.1371\/journal.pone.0088877","volume":"9","author":"SG Palamaner","year":"2014","unstructured":"Palamaner SG, Ramos J, Thomas-Hemak L, Pancholy SB. Association of vitamin D and incident statin induced myalgia\u2014a retrospective cohort study. PLoS ONE. 2014;9(2):e88877.","journal-title":"PLoS ONE"},{"issue":"7","key":"492_CR24","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1185\/03007995.2012.702102","volume":"28","author":"IJ Riphagen","year":"2012","unstructured":"Riphagen IJ, van der Veer E, Muskiet FA, DeJongste MJ. Myopathy during statin therapy in the daily practice of an outpatient cardiology clinic: prevalence, predictors and relation with vitamin D. Curr Med Res Opin. 2012;28(7):1247\u201352.","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"492_CR25","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.clinthera.2014.02.023","volume":"36","author":"K Mergenhagen","year":"2014","unstructured":"Mergenhagen K, Ott M, Heckman K, Rubin LM, Kellick K. Low vitamin D as a risk factor for the development of myalgia in patients taking high-dose simvastatin: a retrospective review. Clin Ther. 2014;36(5):770\u20137.","journal-title":"Clin Ther"},{"issue":"1","key":"492_CR26","first-page":"42","volume":"16","author":"A Eisen","year":"2014","unstructured":"Eisen A, Lev E, Iakobishvilli Z, Porter A, Brosh D, Hasdai D, et al. Low plasma vitamin D levels and muscle-related adverse effects in statin users. Isr Med Assoc J. 2014;16(1):42\u20135.","journal-title":"Isr Med Assoc J"},{"issue":"4","key":"492_CR27","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.mehy.2011.07.007","volume":"77","author":"CJ Glueck","year":"2011","unstructured":"Glueck CJ, Abuchaibe C, Wang P. Symptomatic myositis-myalgia in hypercholesterolemic statin-treated patients with concurrent vitamin D deficiency leading to statin intolerance may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle. Med Hypotheses. 2011;77(4):658\u201361.","journal-title":"Med Hypotheses"},{"issue":"9","key":"492_CR28","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1185\/03007995.2011.598144","volume":"27","author":"CJ Glueck","year":"2011","unstructured":"Glueck CJ, Budhani SB, Masineni SS, Abuchaibe C, Khan N, Wang P, et al. Vitamin D deficiency, myositis-myalgia, and reversible statin intolerance. Curr Med Res Opin. 2011;27(9):1683\u201390.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"492_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4103\/1947-2714.153919","volume":"7","author":"M Khayznikov","year":"2015","unstructured":"Khayznikov M, Hemachrandra K, Pandit R, Kumar A, Wang P, Glueck CJ. Statin intolerance because of myalgia, myositis, myopathy, or myonecrosis can in most cases be safely resolved by vitamin D supplementation. N Am J Med Sci. 2015;7(3):86\u201393.","journal-title":"N Am J Med Sci"},{"issue":"3","key":"492_CR30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4103\/1947-2714.179133","volume":"8","author":"V Jetty","year":"2016","unstructured":"Jetty V, Glueck CJ, Wang P, Shah P, Prince M, Lee K, et al. Safety of 50,000\u2013100,000 units of vitamin D3\/week in vitamin D-deficient, hypercholesterolemic patients with reversible statin intolerance. N Am J Med Sci. 2016;8(3):156\u201362.","journal-title":"N Am J Med Sci"},{"issue":"5","key":"492_CR31","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/qjmed\/hcs001","volume":"105","author":"S Bhattacharyya","year":"2012","unstructured":"Bhattacharyya S, Bhattacharyya K, Maitra A. Possible mechanisms of interaction between statins and vitamin D. QJM. 2012;105(5):487\u201391.","journal-title":"QJM"},{"key":"492_CR32","doi-asserted-by":"publisher","unstructured":"Carlberg C. Nutrigenomics of Vitamin D. Nutrients. 2019;11(3): 676. https:\/\/doi.org\/10.3390\/nu11030676.","DOI":"10.3390\/nu11030676"},{"issue":"6","key":"492_CR33","doi-asserted-by":"publisher","first-page":"C1208","DOI":"10.1152\/ajpcell.00226.2006","volume":"291","author":"AJ Dirks","year":"2006","unstructured":"Dirks AJ, Jones KM. Statin-induced apoptosis and skeletal myopathy. Am J Physiol Cell Physiol. 2006;291(6):C1208\u201312.","journal-title":"Am J Physiol Cell Physiol"},{"key":"492_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijcard.2014.10.118","volume":"178","author":"M Michalska-Kasiczak","year":"2015","unstructured":"Michalska-Kasiczak M, Sahebkar A, Mikhailidis DP, Rysz J, Muntner P, Toth PP, et al. Analysis of vitamin D levels in patients with and without statin-associated myalgia\u2014a systematic review and meta-analysis of 7 studies with 2420 patients. Int J Cardiol. 2015;178:111\u20136.","journal-title":"Int J Cardiol"},{"issue":"6","key":"492_CR35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.reumae.2016.03.001","volume":"12","author":"CA Pereda","year":"2016","unstructured":"Pereda CA, Nishishinya MB. Is there really a relationship between serum vitamin D (25OHD) levels and the musculoskeletal pain associated with statin intake? A systematic review. Reumatol Cl\u00edn (Engl Ed). 2016;12(6):331\u20135.","journal-title":"Reumatol Cl\u00edn (Engl Ed)"},{"issue":"7","key":"492_CR36","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/SMJ.0b013e3181e21088","volume":"103","author":"DS Bell","year":"2010","unstructured":"Bell DS. Resolution of statin-induced myalgias by correcting vitamin D deficiency. South Med J. 2010;103(7):690\u20132.","journal-title":"South Med J"},{"key":"492_CR37","unstructured":"Gerrard G. Fatal statin-induced rhabdomyolysis in the Australian indigenous population and vitamin D replacement\u2014new concepts. Endocr Rev 2011;32(3). https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L70676666&from=export"},{"issue":"3 Suppl","key":"492_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jacl.2014.03.004","volume":"8","author":"RS Rosenson","year":"2014","unstructured":"Rosenson RS, Baker SK, Jacobson TA, Kopecky SL, Parker BA. The National Lipid Association\u2019s Muscle Safety Expert P. An assessment by the Statin Muscle Safety Task Force: 2014 update. J Clin Lipidol. 2014;8(3 Suppl):58\u201371.","journal-title":"J Clin Lipidol"},{"issue":"25 Suppl 2","key":"492_CR39","first-page":"S1","volume":"129","author":"NJ Stone","year":"2014","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S1-45.","journal-title":"Circulation"},{"issue":"12","key":"492_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11883-015-0552-3","volume":"17","author":"T Stulc","year":"2015","unstructured":"Stulc T, Ce\u0161ka R, Gotto AM Jr. Statin intolerance: the clinician\u2019s perspective. Curr Atheroscler Rep. 2015;17(12):69.","journal-title":"Curr Atheroscler Rep"},{"key":"492_CR41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.taap.2016.06.032","volume":"306","author":"GM Camerino","year":"2016","unstructured":"Camerino GM, De Bellis M, Conte E, Liantonio A, Musaraj K, Cannone M, et al. Statin-induced myotoxicity is exacerbated by aging: A biophysical and molecular biology study in rats treated with atorvastatin. Toxicol Appl Pharmacol. 2016;306:36\u201346.","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-021-00492-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-021-00492-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-021-00492-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T06:15:29Z","timestamp":1647324929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-021-00492-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["492"],"URL":"https:\/\/doi.org\/10.1007\/s40256-021-00492-8","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,23]]},"assertion":[{"value":"6 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by the National Natural Science Foundation of China under grant number 81901425.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Qingtao Hou, Caishuang Pang, and Yuqin Chen have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"QH designed the study and wrote the paper. QH and CP collected and analyzed the data. YC contributed to reference collection and data management. All authors read and approved the final manuscript.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}